Gts Securities LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Gts Securities LLC

  • $54.2 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$93.7 - $141.53 $10.3 Million - $15.5 Million
-109,600 Reduced 60.32%
72,100 $9.33 Million
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $1.52 Million - $2.82 Million
22,600 Added 14.2%
181,700 $17.5 Million
Q3 2023

Nov 15, 2023
BUY
$102.5 - $123.59 $16.3 Million - $19.7 Million
159,100 New
159,100 $19.3 Million

Others Institutions Holding SRPT

# of Institutions
470
Shares Held
79.3M
Call Options Held
4.23M
Put Options Held
1.21M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.5B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email